Bimetab Tablets

Adult dose

For ages 12 and older: take 1 tablet once daily.

This drug should not be taken by patients with hypercalcemia, those with sarcoidosis (a systemic inflammatory disease of unknown cause), or individuals with kidney diseases. Individuals who have had allergic reactions to this drug or its components should also avoid taking it. Infants under 12 months, patients with kidney stones, severe renal failure, and those allergic to soybean oil, soy, or peanuts should not take this drug. During the use of this drug, phosphates, calcium salts, oral tetracyclines, antacids, or drugs like levodopa should not be taken together. Especially women undergoing treatment, those who are pregnant or may become pregnant, nursing mothers, premature infants, and infants should consult a professional before taking this drug. It is also important to consult a physician for those with gastrointestinal diseases such as peptic ulcers, chronic ulcerative colitis, or localized colitis, as well as those with heart and circulatory issues. Patients with kidney disorders, hypoproteinemia, or a history of kidney stones should also consult a professional before taking this drug. If symptoms such as nausea, vomiting, diarrhea, skin rashes, abnormal heartbeats, central nervous system problems, dermatitis, hair loss, gastrointestinal disturbances, hypotension, or pulmonary edema appear during the use of this medication, discontinue use immediately and consult with a professional. Furthermore, long-term high-dose use of certain components of this drug may lead to neurological symptoms, so caution is advised. High-dose use may promote gastric ulcers, cause blood sugar control disturbances, lead to gout, or liver damage. High intake may cause gastrointestinal symptoms, hypernatremia, heart failure, or edema; hence, dosage must be strictly followed. Caution is needed when taking together with antialdosterone agents or triamterene as it may raise potassium levels in the blood. Additionally, if symptoms do not improve after one month of use, consult a professional. This drug must be taken at the prescribed dosage and frequency, and urine may appear yellow during treatment, which can affect clinical test results. It is advisable to avoid tannin-containing teas such as green tea or black tea before and after taking this drug. Patients suspected of having a fatty overload should periodically test blood lipid levels to adjust the dosage of this drug. If administered alongside other lipid-lowering agents, the lipid content in this drug must be considered for dosage adjustment. This drug should be stored out of the reach of children, kept in a cool, dry place away from direct sunlight, and kept tightly closed to maintain its quality. It should not be transferred to another container to prevent misuse.

Serious side effects

• Heart failure (cardiac arrest)
• central nervous system dysfunction
• pulmonary edema

Mild side effects

Nausea, vomiting, diarrhea, loose stools, red spots, dermatitis, bad odor during breathing, hair loss, agitation, gastrointestinal disorders, digestive issues, abdominal pain, hypotension, pulmonary edema, sensory neuropathy or neurological symptoms, hematological adverse reactions, promotion of peptic ulcers, impaired glucose tolerance, hyperuricemia, liver damage, hypernatremia, congestive heart failure, edema, hyperkalemia, yellowing of urine, abnormal plasma lipid levels

This drug should be stored in a sealed container to protect it from air, and it is best to keep it at room temperature between 1 to 30 degrees Celsius. Proper storage will maintain the drug's efficacy and prevent degradation.

Appearance

Brown oval film-coated tablet

Package unit

Bottle - 60 tablets per bottle, Box - 120 tablets per box [(60 tablets/bottle x 2)]